Literature DB >> 9886243

Role of CD8+ and WC-1+ gamma/delta T cells in resistance to Mycobacterium bovis infection in the SCID-bo mouse.

R A Smith1, J M Kreeger, A J Alvarez, J C Goin, W C Davis, D L Whipple, D M Estes.   

Abstract

The role of various effector T cell populations in the bovine immune response to Mycobacterium bovis infection is poorly understood. This is largely due to the difficulties associated with performing in vivo challenge studies in the natural host species. In this report, we utilized a fetal bovine-severe combined immunodeficient (SCID-bo) xenochimeric mouse model to study the protective role of two putative effector cell types, CD8+ T cells and a subpopulation of gamma/delta T cells that express WC-1, a member of the cysteine-rich scavenger receptor superfamily (CRSR). We demonstrate that CD8+ T cells play a key role in protection and contribute substantially to bovine IFN-gamma mRNA levels at 30 days post-infection. The role of WC-1 bearing cells to protection was less definitive but our results suggest that this population may play a pivotal role early in infection. Granuloma architecture was altered in anti-WC-1 (ILA29) but not anti-CD8 (ILA51) -treated animals, suggesting that this population may be involved in recruitment of various cell types to sites of infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886243     DOI: 10.1002/jlb.65.1.28

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  13 in total

1.  Circulating gamma delta T cells in response to Salmonella enterica serovar enteritidis exposure in chickens.

Authors:  Angela Berndt; Jana Pieper; Ulrich Methner
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Measuring bovine γδ T cell function at the site of Mycobacterium bovis infection.

Authors:  Rachel A Rusk; Mitchell V Palmer; W Ray Waters; Jodi L McGill
Journal:  Vet Immunol Immunopathol       Date:  2017-10-27       Impact factor: 2.046

4.  Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D(3).

Authors:  W R Waters; B J Nonnecke; T E Rahner; M V Palmer; D L Whipple; R L Horst
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

5.  Responses of bovine WC1(+) gammadelta T cells to protein and nonprotein antigens of Mycobacterium bovis.

Authors:  Michael D Welsh; Hilary E Kennedy; Allister J Smyth; R Martyn Girvin; Peter Andersen; John M Pollock
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  In vitro responsiveness of gammadelta T cells from Mycobacterium bovis-infected cattle to mycobacterial antigens: predominant involvement of WC1(+) cells.

Authors:  A J Smyth; M D Welsh; R M Girvin; J M Pollock
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

7.  Modulation of immune responses to Mycobacterium bovis in cattle depleted of WC1(+) gamma delta T cells.

Authors:  Hilary E Kennedy; Michael D Welsh; David G Bryson; Joseph P Cassidy; Fiona I Forster; Christopher J Howard; Robert A Collins; John M Pollock
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

8.  Gamma interferon production by bovine gamma delta T cells following stimulation with mycobacterial mycolylarabinogalactan peptidoglycan.

Authors:  B Vesosky; O C Turner; J Turner; I M Orme
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

9.  Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells.

Authors:  W R Waters; T E Rahner; M V Palmer; D Cheng; B J Nonnecke; D L Whipple
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

Review 10.  Tuberculosis immunity: opportunities from studies with cattle.

Authors:  W Ray Waters; Mitchell V Palmer; Tyler C Thacker; William C Davis; Srinand Sreevatsan; Paul Coussens; Kieran G Meade; Jayne C Hope; D Mark Estes
Journal:  Clin Dev Immunol       Date:  2010-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.